Disruption of SHP1/NMDA receptor signaling in spinal cord dorsal horn alleviated inflammatory pain

Neuropharmacology
Li YangXiao-Dong Hu

Abstract

Src-homology 2 domain-containing protein tyrosine phosphatase-1 (SHP1) is one of the non-receptor-like phosphatases that are highly enriched in hematopoietic cells. Although accumulating evidence has implicated the protein tyrosine phosphatases in the regulation of nociceptive transmission and plasticity, it is largely unknown whether SHP1 was expressed in pain-related spinal cord dorsal horn and engaged in the synaptic modification of nociceptive signals. Here we found that SHP1 was present in spinal neurons of rats and functionally coupled to GluN2A subunit-containing N-methyl-d-aspartate subtype of glutamate receptors, one of the key players in central sensitization of nociceptive behaviors. SHP1 interacted with a membrane-proximal region within the cytoplasmic tail of GluN2A. This interaction was necessary to stimulate SHP1 activity and more importantly, restrict SHP1 signaling to specifically enhance the tyrosine phosphorylation of GluN2A during inflammatory pain. Electrophysiological and behavioral studies showed that SHP1 binding potentiated GluN2A currents and evoked GluN2A-dependent pain hypersensitivity. The siRNA-mediated knockdown of SHP1 or interference with SHP1/GluN2A interaction by a synthetic peptide alleviated...Continue Reading

References

Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·H LiuA I Basbaum
Aug 22, 1997·The Journal of Biological Chemistry·A K SomaniD R Branch
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·T TezukaT Yamamoto
May 24, 2003·Journal of Neuroscience Methods·Judith Thomas-CrusellsClaudio Rivera
Oct 8, 2003·Neuropharmacology·Lorraine V Kalia, Michael W Salter
Mar 23, 2004·Nature Reviews. Neuroscience·Michael W Salter, Lorraine V Kalia
Nov 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ying LinR Suzanne Zukin
Apr 23, 2005·Biochemical and Biophysical Research Communications·Robert Roskoski
Sep 23, 2006·The EMBO Journal·Lorraine V KaliaMichael W Salter
May 22, 2007·Nature Reviews. Neuroscience·C Geoffrey Lau, R Suzanne Zukin
Sep 6, 2007·Neuron·Camilla Bellone, Roger A Nicoll
Mar 18, 2009·Immunological Reviews·Ulrike Lorenz
Oct 17, 2009·The EMBO Journal·Sachiko TaniguchiTadashi Yamamoto
Oct 31, 2009·Neuron·Takashi HayashiRichard L Huganir
Feb 5, 2011·Anti-cancer Agents in Medicinal Chemistry·Pilar López-RuizBegoña Colás
Jul 5, 2011·Nature Neuroscience·Chihiro NozakiBrigitte L Kieffer
Feb 22, 2012·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Antonio Sanz-ClementeKatherine W Roche
Jul 10, 2013·Trends in Neurosciences·Hideto Takahashi, Ann Marie Craig
Dec 3, 2013·European Journal of Pharmacology·John Q WangLi-Min Mao
Jul 22, 2014·Current Cancer Drug Targets·Wen-Qing HuangChi-Meng Tzeng
Sep 6, 2015·European Journal of Medical Genetics·Mylène TajanArmelle Yart
Oct 16, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xiao-Dong HuXian Yang
Jan 12, 2016·The Journal of Clinical Investigation·Bao-Chun JiangYong-Jing Gao

❮ Previous
Next ❯

Citations

Mar 18, 2021·European Journal of Pharmacology·Lin YaoXiao-Dong Hu
Feb 6, 2019·Neuropharmacology·Zi-Yang ZhangXiao-Dong Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.